Literature DB >> 22649220

A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1.

D L Raja Rayan1, A Haworth, R Sud, E Matthews, D Fialho, J Burge, S Portaro, S Schorge, K Tuin, P Lunt, M McEntagart, A Toscano, M B Davis, M G Hanna.   

Abstract

OBJECTIVE: To assess whether exon deletions or duplications in CLCN1 are associated with recessive myotonia congenita (MC).
METHODS: We performed detailed clinical and electrophysiologic characterization in 60 patients with phenotypes consistent with MC. DNA sequencing of CLCN1 followed by multiplex ligation-dependent probe amplification to screen for exon copy number variation was undertaken in all patients.
RESULTS: Exon deletions or duplications in CLCN1 were identified in 6% of patients with MC. Half had heterozygous exonic rearrangements. The other 2 patients (50%), with severe disabling infantile onset myotonia, were identified with both a homozygous mutation, Pro744Thr, which functional electrophysiology studies suggested was nonpathogenic, and a triplication/homozygous duplication involving exons 8-14, suggesting an explanation for the severe phenotype.
CONCLUSIONS: These data indicate that copy number variation in CLCN1 may be an important cause of recessive MC. Our observations suggest that it is important to check for exon deletions and duplications as part of the genetic analysis of patients with recessive MC, especially in patients in whom sequencing identifies no mutations or only a single recessive mutation. These results also indicate that additional, as yet unidentified, genetic mechanisms account for cases not currently explained by either CLCN1 point mutations or exonic deletions or duplications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649220      PMCID: PMC3369509          DOI: 10.1212/WNL.0b013e318259e19c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.

Authors:  John W Scott; Simon A Hawley; Kevin A Green; Miliea Anis; Greg Stewart; Gillian A Scullion; David G Norman; D Grahame Hardie
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 3.  Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.

Authors:  Dipa L Raja Rayan; Michael G Hanna
Journal:  Curr Opin Neurol       Date:  2010-10       Impact factor: 5.710

Review 4.  Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome.

Authors:  J Zhang; L Feuk; G E Duggan; R Khaja; S W Scherer
Journal:  Cytogenet Genome Res       Date:  2006       Impact factor: 1.636

5.  Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita.

Authors:  A L George; K Sloan-Brown; G M Fenichel; G A Mitchell; R Spiegel; R M Pascuzzi
Journal:  Hum Mol Genet       Date:  1994-11       Impact factor: 6.150

6.  Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia.

Authors:  C Meyer-Kleine; K Steinmeyer; K Ricker; T J Jentsch; M C Koch
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

7.  Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions.

Authors:  D Fialho; S Schorge; U Pucovska; N P Davies; R Labrum; A Haworth; E Stanley; R Sud; W Wakeling; M B Davis; D M Kullmann; M G Hanna
Journal:  Brain       Date:  2007-10-11       Impact factor: 13.501

8.  A novel N440K sodium channel mutation causes myotonia with exercise-induced weakness--exclusion of CLCN1 exon deletion/duplication by MLPA.

Authors:  F Lehmann-Horn; M Orth; M Kuhn; K Jurkat-Rott
Journal:  Acta Myol       Date:  2011-10

9.  Functional and structural conservation of CBS domains from CLC chloride channels.

Authors:  Raúl Estévez; Michael Pusch; Carles Ferrer-Costa; Modesto Orozco; Thomas J Jentsch
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

10.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

View more
  8 in total

1.  Clinical Utility Gene Card for: autosomal dominant myotonia congenita (Thomsen Disease).

Authors:  David J Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-04-26       Impact factor: 4.246

2.  Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita.

Authors:  Simona Portaro; Concetta Altamura; Norma Licata; Giulia M Camerino; Paola Imbrici; Olimpia Musumeci; Carmelo Rodolico; Diana Conte Camerino; Antonio Toscano; Jean-François Desaphy
Journal:  Neuromolecular Med       Date:  2015-05-26       Impact factor: 3.843

Review 3.  ClC-1 chloride channels: state-of-the-art research and future challenges.

Authors:  Paola Imbrici; Concetta Altamura; Mauro Pessia; Renato Mantegazza; Jean-François Desaphy; Diana Conte Camerino
Journal:  Front Cell Neurosci       Date:  2015-04-27       Impact factor: 5.505

Review 4.  An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies.

Authors:  Fernando Morales; Michael Pusch
Journal:  Front Neurol       Date:  2020-01-17       Impact factor: 4.003

5.  ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation.

Authors:  P Imbrici; L Maggi; G F Mangiatordi; M M Dinardo; C Altamura; R Brugnoni; D Alberga; G Lauria Pinter; G Ricci; G Siciliano; R Micheli; G Annicchiarico; G Lattanzi; O Nicolotti; L Morandi; P Bernasconi; J-F Desaphy; R Mantegazza; D Conte Camerino
Journal:  J Physiol       Date:  2015-07-14       Impact factor: 5.182

6.  Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.

Authors:  Jaya R Trivedi; Brian Bundy; Jeffrey Statland; Mohammad Salajegheh; Dipa Raja Rayan; Shannon L Venance; Yunxia Wang; Doreen Fialho; Emma Matthews; James Cleland; Nina Gorham; Laura Herbelin; Stephen Cannon; Anthony Amato; Robert C Griggs; Michael G Hanna; Richard J Barohn
Journal:  Brain       Date:  2013-06-13       Impact factor: 13.501

Review 7.  Next-generation sequencing in understanding complex neurological disease.

Authors:  Adam E Handel; Giulio Disanto; Sreeram V Ramagopalan
Journal:  Expert Rev Neurother       Date:  2013-02       Impact factor: 4.618

Review 8.  Genetic neurological channelopathies: molecular genetics and clinical phenotypes.

Authors:  J Spillane; D M Kullmann; M G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-11       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.